tiprankstipranks
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market

Sunshine Biopharma (SBFM) Financial Statements

263 Followers

Sunshine Biopharma Financial Overview

Sunshine Biopharma's market cap is currently ―. The company's EPS TTM is $-19.054; its P/E ratio is -0.05; Sunshine Biopharma is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 5.96M$ 5.56M$ 4.89M$ 3.94M$ 132.81K
Gross Profit$ 1.99M$ 1.95M$ 1.83M$ 1.49M$ 67.03K
EBIT$ -572.00K$ -786.84K$ -1.62M$ -23.36M$ -1.46M
EBITDA$ -534.80K$ -751.95K$ -1.58M-$ -1.46M
Net Income Common Stockholders$ -651.48K$ -902.11K$ -1.70M$ -23.51M$ -1.46M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 18.85M$ 19.73M$ 19.29M$ 21.83M$ 40.56M
Total Assets$ 27.65M$ 28.41M$ 26.99M$ 29.24M$ 40.86M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -18.85M$ -19.73M$ -19.29M$ -21.83M$ -40.56M
Total Liabilities$ 5.69M$ 5.30M$ 7.56M$ 7.62M$ 480.21K
Stockholders Equity$ 21.96M$ 23.11M$ 19.43M$ 21.63M$ 40.38M
Cash Flow-
Free Cash Flow$ -438.43K$ -4.04M$ -2.00M$ -2.52M$ -1.12M
Operating Cash Flow$ -457.29K$ -3.78M$ -1.85M$ -2.25M$ -1.12M
Investing Cash Flow$ 18.86K$ -259.48K$ -146.30K$ -14.62M-
Financing Cash Flow$ -63.57K$ 4.06M$ -538.30K$ -2.10M$ 0.00
Currency in USD

Sunshine Biopharma Earnings and Revenue History

Sunshine Biopharma Debt to Assets

Sunshine Biopharma Cash Flow

Sunshine Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis